← back to database
Bioeconomy Capital helps early-stage biotech startups grow by accelerating the biotechnology revolution. It leverages startup operational expertise, product development experience, and a proprietary blueprint distilled from five decades of synthetic biology and engineering. The firm funds and guides ventures to build and deploy technological capabilities that become infrastructure for the 21st-century economy. The category is B2B biotech venture funding, focusing on synthetic biology and engineering-driven life sciences companies.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026